Optimal dosing of zoledronate to prevent fractures: improving risk‐benefit balance
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Internal Medicine"
DOI: 10.1111/joim.12915
Abstract: In their prospective, randomized, placebo-controlled, double-blind trial that investigated anti-fracture efficacy of zoledronate in a total of 2000 osteopenic postmenopausal women aged over 65 years, Reid et al. [1, 2] provides crucial evidence that is highly… read more here.
Keywords: optimal dosing; risk; zoledronate; dosing zoledronate ... See more keywords